Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of LY3314814 on the Pharmacokinetics of Dabigatran in Healthy Subjects

NCT02568397 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02568397
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02568397 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of LY3314814 on the Pharmacokinetics of Dabigatran in Healthy Subjects
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2015
Completion date
January 31, 2016
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy